epoetin delta: Clinical Trials

3 trials of epoetin delta, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1
Phase 41Terminated 1

Follow epoetin delta: new trials by email Literature Review of epoetin delta trials Research Report on epoetin delta

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)
DYNEPO (epoetin delta) - Anemia, Kidney Diseases
TerminatedShire32008-04-252021-06-25
Dynepo Long-Term Safety Study
Dynepo - Anemia, Kidney Failure, Chronic
Phase 4TerminatedShire1522007-06-062021-07-13
Dynepo Infrequent Dosing Study
Dynepo (Epoetin delta), Dynepo - Anemia, Kidney Failure
Phase 3TerminatedShire4072006-10-302021-06-14

Conditions studied

Anemia (3)  ·  Kidney Failure, Chronic (2)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Kidney Diseases (1)  ·  Renal Insufficiency (1)

Sponsors

Shire (3)

Countries

Belgium (2)  ·  Germany (2)  ·  Austria (1)  ·  France (1)  ·  Italy (1)  ·  Spain (1)  ·  United Kingdom (1)

Results publications

PMID 17999759, PMID 36791280